Application 204028
- Type
- ANDA
- Sponsor
- CASI PHARMS INC
Related Records
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | TABLET, EXTENDED RELEASE;ORAL | EQ 50MG BASE | No | No |
| 002 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | TABLET, EXTENDED RELEASE;ORAL | EQ 100MG BASE | No | No |
| 003 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | TABLET, EXTENDED RELEASE;ORAL | EQ 25MG BASE | No | No |
Documents
| Document | Title | Submission type | Submission no. | Date | Storage |
|---|---|---|---|---|---|
| 32492 | 0 | ORIG | 1 | 2015-07-08 | Cached in FDA.report object storage |